[The use of low molecular weight heparins in patients with acute ST-elevated myocardial infarction].

@article{Petrovi2006TheUO,
  title={[The use of low molecular weight heparins in patients with acute ST-elevated myocardial infarction].},
  author={Milovan Petrovi{\'c} and Gordana Pani{\'c} and Tibor Canji and Ilija Srdanovi{\'c} and Vladimir G. Ivanov{\'i}c and Dragan Benc},
  journal={Medicinski pregled},
  year={2006},
  volume={59 9-10},
  pages={476-81}
}
UNLABELLED INTRODUCTION According to the published guidelines for the management of acute coronary syndromes (ACS), treatment of acute ST-elevated myocardial infarction is based on rapid revascularization, either mechanical or pharmacological. Pharmacological revascularization consists of fibrinolytic therapy with antiplatelet and anticoagulant therapy. In regard to the anticoagulant therapy, low molecular weight heparins (LMWHs) are of special importance. LMWHs cause less complications… CONTINUE READING